(1 - 19 von 21
)
Special Report: Inside the battle for Genzyme's future - Reuters
www.reuters.com
At a recent dinner to honor the achievements of Henri Termeer, chief executive of biotechnology company Genzyme, Ananth Raman broke down as he recalled the...
Royalty Pharma Chairman Writes Open Letter to Elan Board
www.finanznachrichten.de
NEW YORK, June 17, PRNewswire/ --Royalty Pharma announced today that Rory Riggs, Chairman and Co-Founder of the Royalty Pharma group, is sending the...
Royalty Pharma Chairman Rory Riggs Sends Open Letter to Elan Board...
www.benzinga.com
Royalty Pharma announced today that Rory Riggs, Chairman and Co-Founder of the Royalty Pharma group, is sending the following open letter to the Board of ...
Royalty Pharma Sends Open Letter To Board Of Elan
www.finanznachrichten.de
DUBLIN (dpa-AFX) - The Chairman and Co-Founder of Royalty Pharma Group, Rory Riggs, sent an open letter to the Board of Elan Corporation plc (ELN). In the letter, the ...
GeneNews announces management changes to support commercialization of...
www.finanznachrichten.de
Rory Riggs, Chair of the Board of Directors. "In the interim, Dr. Dreismann's extensive experience and leadership at Roche Molecular ...
Genenews adds two members to its Board of Directors
www.bionity.com
GeneNews Limited announced its shareholders recently elected two additional members to its Board of Directors, Mr. Harry A. Glorikian and Ms. Fran Tuttle. They...
Genenews adds two members to its Board of Directors
www.finanznachrichten.de
Rory Riggs, Mr. James Howard-Tripp, Mr. Garth MacRae, Dr. Heiner Dreismann, Dr. C. C. Liew and Dr. K. Wayne Marshall on the ...
GeneNews Announces Management and Board Changes
www.globenewswire.com
succeeding Rory Riggs, who has stepped down as Chair, but ...
Genzyme Biosurgery Shareholders Receive $64 Million Settlement in...
www.finanznachrichten.de
Rory Riggs, principal of Balfour, LLC and former President of Biomatrix, Inc., and John Lewis, ...
Director Increases Ownership in GeneNews Limited Toronto Stock...
www.globenewswire.com
TORONTO, Sept. 19, (GLOBE NEWSWIRE) -- GeneNews Limited: Mr. Rory Riggs, a director of GeneNews Limited (“GeneNews”) (TSX:GEN), announces that, pursuant to a private placement which took place on September 1, (the “Private Placement”), he, as an individual, personally acquired ...
Spurned suitor still chasing elusive Elan takeover deal
www.irishtimes.com
The chief executive of Royalty Pharma is still keen to talk to Ireland’s largest indigenous pharma group about making a deal work
489th Bomb Group gains new commander
www.10af.afrc.af.mil
U.S. Air Force Staff Sgt. Rory Riggs, stands at attention outside the commander's B-1 Lancer during the 489th Bomb Group change of command ceremony at ...
An Index Methodology for Diversifying Business Risk
www.exchangetradedfunds.com
... exhibiting comparable beta and volatility. view more. Source: Rory Riggs, Jonathan Chandler and Mark T. Finn The Journal of Index Investing Winter
Nucelis debuts as a new San Diego biotech - The San Diego...
www.sandiegouniontribune.com
Nucelis, a spin-off from agricultural biotech Cibus, marked its debut as an independent company Wednesday evening.
Nucelis inaugurates its pilot plant - Bio-based News -
renewable-carbon.eu
(L to R): Dr. Sean O'Connor, Nucelis' President and CEO; The Honorable Mayor Bob Filner; Rory Riggs, Chairman of the Board, Nucelis [PHOTO CREDIT: Jeff ...
Stockwatch
www.stockwatch.com
No Hype - just the Facts. Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, Montreal, Nasdaq, NYSE, Amex and OTC Markets.
Lessons from Health Care: Building a Stratified Index | Wealth...
www.wealthmanagement.com
Rory Riggs, CEO of Syntax Advisors, talks about new approaches to building equity indexes.
New Ventures Closes $90M Healthcare/Digital Medicine Fund
apnews.com
The management team of the Fund consists of Mark Finn, Rory Riggs, Jonathan Finn, Dr. Richard Warburg, and Harry Glorikian. The partners ...
Genzyme neutral (Merrill Lynch) | aktiencheck.de
www.aktiencheck.de
Rory Riggs sowie des gegenwärtig im Besitz von Aktienpaketen befindlichen John Lewis eine erste ...
sortiert nach Relevanz / Datum